Connect with us

Press Releases

Johnson & Johnson Vision Receives Approval in Canada

Health Canada approves ACUVUE Theravision with Ketotifen, the first drug-releasing contact lens that provides vision correction to people experiencing itchy allergy eyes.




(PRESS RELEASE) JACKSONVILLE, FL — Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, received Health Canada approval for the first and only daily disposable contact lens for vision correction in patients who experience itchy allergy eyes due to allergic conjunctivitis: ACUVUE Theravision with Ketotifen1. The lens contains an H1 histamine receptor antagonist for the prevention of itchy allergy eyes associated with allergic conjunctivitis experienced by contact lens users to promote comfortable contact lens wear. In March 2021, ACUVUE Theravision with Ketotifen received its first regulatory approval from the Japanese Ministry of Health, Labour and Welfare.

“We are proud to mark another step forward in delivering this important innovation to help relieve patients from allergic eye itch while continuing to comfortably wear contact lenses,” said Xiao-Yu Song, MD, PhD, Global Head of Research & Development, Johnson & Johnson Vision. “We look forward to working with additional health authorities to make ACUVUE Theravision with Ketotifen available to more patients around the world.”

Itchy allergy eyes can impact vision, and this becomes even more problematic for contact lens wearers — most of whom resort to rubbing their eyes.ǂ Data show that nearly 8 out of 10 contact lens wearers feel frustrated when their eye allergies interfere with normal contact lens wear. ACUVUE Theravision with Ketotifen may help people continue to wear their contact lenses for vision correction, and prevent allergic eye itch, without the need for allergy eye drops.

ACUVUE is the most trusted brand for eye care professionals globally^ and has built a legacy by making contact lenses that are unbeaten in comfort†,2,3,4 across 47 clinical studies. ACUVUE Theravision with Ketotifen is the latest in a long line of innovative contact lenses from Johnson & Johnson Vision since the company introduced the world’s first daily disposable soft contact lens three decades ago. ACUVUE Theravision with Ketotifen is the first in an entirely new contact lens category and brings forward a better contact lens wearing experience for patients with allergic eye itch.


Sponsored by Shamir

Customer Focused, Service Oriented, Forward Thinking

Shamir is the recognized world leader in custom-designed technology for life improvement, fashion, performance sports, occupational single vision, and progressive lenses. Our values, the driving force behind our ideas and actions, keep the ECP in the center. Every Shamir representative is personally committed to our customers’ vision, and to providing the best service and support to meet and exceed their expectations, all with a personal touch.

Click here for more information.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular